Quest Diagnostics Inc.
3 Giralda Farms
Madison
New Jersey
07940
United States
Tel: 973-520-2700
Website: http://www.questdiagnostics.com/
614 articles about Quest Diagnostics Inc.
-
Quest Diagnostics to Speak at the 2018 Morgan Stanley Global Healthcare Conference
9/7/2018
Quest Diagnostics Incorporated announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City.
-
Quest Diagnostics Reports Second Quarter 2018 Financial Results
7/24/2018
Second quarter revenues of $1.92 billion, up 3.0% from 2017
-
Quest Diagnostics To Release Second Quarter 2018 Financial Results On July 24
7/11/2018
Quest Diagnostics Incorporated announced that it will report second quarter 2018 results on Tuesday, July 24, 2018
-
Quest Diagnostics To Speak At The William Blair 38th Annual Growth Stock Conference
6/4/2018
Quest Diagnostics Incorporated announced that it is scheduled to speak at the William Blair 38th Annual Growth Stock Conference in Chicago.
-
Quest Diagnostics adds Helen Torley to Board of Directors
5/17/2018
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Helen I. Torley was elected to serve as a director at the company's 2018 Annual Meeting of Stockholders, expanding the Board of Directors to 10 members.
-
Quest Diagnostics Reports First Quarter 2018 Financial Results
4/19/2018
Quest Diagnostics Incorporated announced today financial results for the first quarter ended March 31, 2018.
-
Quest Diagnostics to Release First Quarter 2018 Financial Results on April 19
4/6/2018
Quest Diagnostics Inc. announced that it will report first quarter 2018 results on Thursday, April 19, 2018.
-
Quest Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results; Provides Guidance For Full Year 2018
2/5/2018
Quest Diagnostics announced today financial results for the fourth quarter and full year ended December 31, 2017.
-
Quest Diagnostics Completes Acquisition of MedXM
2/2/2018
Transaction expands Quest’s scale and reach in the mobile provider segment and bolsters its extended care capabilities.
-
Quest Diagnostics to Acquire MedXM, Expanding its Health Risk Assessment Services to Close Gaps in Care
1/23/2018
The acquisition will expand Quest's scale and reach in the mobile/home segment and bolster its overall capabilities in extended care.
-
Quest Diagnostics to Release Fourth Quarter and Full Year 2017 Financial Results on February 1
1/19/2018
Quest Diagnostics announced that it will report fourth quarter and full year 2017 results on Thursday, February 1, 2018, before the market opens.
-
Quest Diagnostics Completes Acquisition of Shiel Medical Laboratory From Fresenius Medical Care
12/12/2017
Quest Diagnostics today announced it has completed its previously announced acquisition of the Shiel Medical Laboratory business from Fresenius Medical Care, the premier healthcare company focused on delivering the highest quality care to people with renal and other chronic conditions.
-
Quest Diagnostics Supports Suit Against HHS Charging That CMS Ignored Congressional Intent in Implementing New Clinical Lab Payment System
12/11/2017
The lawsuit by ACLA asserts that CMS, operating under the purview of HHS, ignored congressional intent and instituted a highly flawed data reporting process in advance of setting market rates under the PAMA.
-
Quest Diagnostics Completes Acquisition of Cleveland HeartLab and Formalizes R&D Collaboration With Cleveland Clinic
12/4/2017
Quest will establish a national center of excellence focused on heart disease diagnostics within Cleveland HeartLab's existing 25,000 square-foot clinical laboratory facility in Cleveland.
-
Quest Diag. Declares Quarterly Cash Dividend
11/29/2017
Quest Diagnostics the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on January 24, 2018 to shareholders of record of Quest Diagnostics common stock on January 9, 2018.
-
Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests
11/21/2017
The company expects the impact of the final fee schedule rates under PAMA to be approximately 4% in 2018, and approximately 10% in both 2019 and 2020.
-
Clinical Genomics and Quest Diagnostics Announce FDA 510(K) Clearance of Insure ONE
11/13/2017
InSure ONE is a convenient at-home collection, fecal immunochemical test intended to detect blood in stool, that may improve compliance for screening programs.
-
Quest Diagnostics Acquires California Laboratory Associates
10/30/2017
Quest will add several CLA patient service centers to its network in the San Fernando Valley and neighboring communities.
-
Advantage Capital Portfolio Company Cleveland HeartLab, Inc. Acquired by Quest Diagnostics
10/20/2017
Advantage Capital portfolio company Cleveland HeartLab, Inc. announced its acquisition by Quest Diagnostics, one of the largest laboratory service providers in the country.
-
Quest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland Clinic
10/19/2017
Quest Diagnostics today announced it has formed a definitive agreement to acquire Cleveland HeartLab, a leader in innovative diagnostic services for managing cardiovascular disease, from equity investors, including Cleveland Clinic.